XML 99 R18.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2018
Stockholders' Equity Note [Abstract] |
Stockholders' Equity | Stockholders' Equity 1.625% Notes Conversion. As described in Note 7, “Debt,” we issued 0.6 million shares of our common stock in connection with the conversion of the 1.625% Notes in the third quarter of 2018. Exchange. As described in Note 7, “Debt,” we issued 1.8 million shares of our common stock in connection with the exchange of the 1.625% Notes in March 2018. 1.125% Warrants In connection with the Call Spread Overlay transaction described in Note 8, “Derivatives,” in 2013, we issued 13.5 million warrants with a strike price of $53.8475 per share. Under certain circumstances, beginning in April 2020, if the price of our common stock exceeds the strike price of the 1.125% Warrants, we will be obligated to issue shares of our common stock subject to a share delivery cap. The 1.125% Warrants could separately have a dilutive effect to the extent that the market value per share of our common stock exceeds the applicable strike price of the 1.125% Warrants. Refer to Note 3, “Net Income (Loss) per Share,” for dilution information for the periods presented. We will not receive any additional proceeds if the 1.125% Warrants are exercised. Following the transactions described below, 7.7 million of the 1.125% Warrants remain outstanding. As described in Note 8, “Derivatives,” in the second and third quarters of 2018, we entered into privately negotiated termination agreements with each of the Counterparties to partially terminate the Call Spread Overlay, in notional amounts corresponding to the aggregate principal amount of the 1.125% Notes purchased. In the third quarter of 2018, we paid $306 million to the Counterparties for the termination of 3.4 million of the 1.125% Warrants outstanding, which resulted in a reduction of additional paid-in-capital for the same amount. In the second quarter of 2018, we paid $113 million to the Counterparties for the termination of 2.4 million of the 1.125% Warrants outstanding, which resulted in a reduction of additional paid-in capital for the same amount. Share-Based Compensation In connection with our equity incentive plans and employee stock purchase plan, approximately 281,000 shares of common stock vested or were purchased, net of shares used to settle employees’ income tax obligations, during the nine months ended September 30, 2018. Share-based compensation is generally recorded to “General and administrative expenses” in the accompanying consolidated statements of operations. Total share-based compensation expense for the three and nine months ended September 30, 2018, amounted to $7 million and $20 million, respectively. Total share-based compensation expense for the three months ended September 30, 2017, amounted to $3 million. Total share-based compensation expense for the nine months ended September 30, 2017, amounted to $38 million, of which $23 million was recorded to “Restructuring and separation costs” in the accompanying consolidated statements of operations. As of September 30, 2018, there was $41 million of total unrecognized compensation expense related to unvested restricted stock awards (RSAs), performance stock awards (PSAs), and performance stock units (PSUs), which we expect to recognize over a remaining weighted-average period of 2.8 years, 0.4 years and 2.3 years, respectively. This unrecognized compensation cost assumes an estimated forfeiture rate of 12.1% for non-executive employees as of September 30, 2018. Also as of September 30, 2018, there was $11 million of total unrecognized compensation expense related to unvested stock options, which we expect to recognize over a weighted-average period of 2.0 years. No stock options were granted or exercised in the nine months ended September 30, 2018. Activity for RSAs, PSAs and PSUs, for the nine months ended September 30, 2018, is summarized below:
| Restricted Stock Awards |  | Performance Stock Awards |  | Performance Stock Units |  | Total |  | Weighted Average Grant Date Fair Value
Unvested balance, December 31, 2017 | 401,804 |  |  | 84,762 |  |  | 91,828 |  |  | 578,394 |  |  | $ | 58.35 |
Granted | 353,618 |  |  | — |  |  | 212,926 |  |  | 566,544 |  |  | 73.85 |
Vested | (188,954 | ) |  | (32,929 | ) |  | — |  |  | (221,883 | ) |  | 57.87 |
Forfeited | (152,243 | ) |  | (48,701 | ) |  | (104,527 | ) |  | (305,471 | ) |  | 63.67 |
Unvested balance, September 30, 2018 | 414,225 |  |  | 3,132 |  |  | 200,227 |  |  | 617,584 |  |  | 70.11 |
The aggregate fair values of RSAs, PSAs and PSUs granted and vested are presented in the following table:
| Nine Months Ended September 30,
| 2018 |  | 2017
| (In millions)
Granted: |  |  |
Restricted stock awards | $ | 26 |  |  | $ | 19 |
Performance stock units | 16 |  |  | 16 |
| $ | 42 |  |  | $ | 35 |
Vested: |  |  |
Restricted stock awards | $ | 14 |  |  | $ | 21 |
Performance stock awards | 3 |  |  | 15 |
Performance stock units | — |  |  | 9 |
| $ | 17 |  |  | $ | 45 |

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration